Back
Enliven Therapeutics Vs. REV Group Industry Stock Comparison
Sell
31
ELVN
Enliven Therapeutics
Last Price:
24.13
Seasonality Move:
-7.59%
Buy
74
REVG
REV Group
Last Price:
33.73
Seasonality Move:
2.81%
Sell
31
Enliven Therapeutics (ELVN)
is a Sell
Is Enliven Therapeutics a Buy, Sell or Hold?
- The current Enliven Therapeutics [ELVN] share price is $24.08. The Score for ELVN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ELVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
REV Group (REVG)
is a Buy
Is REV Group a Buy, Sell or Hold?
- The current REV Group [REVG] share price is $33.69. The Score for REVG is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- REVG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ELVN Stock Price Chart
What is Enliven Therapeutics's stock price today?
-
The Enliven Therapeutics share price today is $24.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.
REVG Stock Price Chart
ELVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 43.48 | Sell |
| Chaikin Money Flow: | 123245 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.71 - 27.13) | Sell |
| Bollinger Bands (100): | (22.53 - 27.37) | Sell |
REVG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 65.86 | Buy |
| Chaikin Money Flow: | -681203 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.5 - 31.6) | Buy |
| Bollinger Bands (100): | (26.92 - 30.28) | Buy |
ELVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.09 | Sell |
| 20-day SMA: | 24.67 | Sell |
| 50-day SMA: | 26.69 | Sell |
| 200-day SMA: | 22.58 | Buy |
| 8-day EMA: | 24.24 | Sell |
| 20-day EMA: | 24.91 | Sell |
| 50-day EMA: | 25.49 | Sell |
| 200-day EMA: | 22.86 | Buy |
REVG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.23 | Buy |
| 20-day SMA: | 30.66 | Buy |
| 50-day SMA: | 29.04 | Buy |
| 200-day SMA: | 26.02 | Buy |
| 8-day EMA: | 31.23 | Buy |
| 20-day EMA: | 30.62 | Buy |
| 50-day EMA: | 29.53 | Buy |
| 200-day EMA: | 25.93 | Buy |
Enliven Therapeutics Earnings Growth & ELVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.
REV Group Earnings Growth & REVG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.14 per share, an increase this year of $0.41 per share, and an increase next year of $0.52 per share.
Enliven Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
REV Group Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||